Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$67.11
+0.8%
$56.50
$43.38
$67.52
$9.08B1.111.15 million shs977,500 shs
SOLV
Solventum
$59.34
+1.7%
$63.32
$56.72
$96.05
$10.25BN/A2.65 million shs5.80 million shs
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$334.75
0.0%
$327.94
$157.00
$334.90
$12.57B0.88968,088 shs4.71 million shs
Teleflex Incorporated stock logo
TFX
Teleflex
$209.07
+1.2%
$211.47
$177.63
$262.97
$9.85B1.13343,414 shs1.16 million shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.00%+1.96%+29.18%+21.55%+20.31%
SOLV
Solventum
0.00%-1.84%-8.21%+5,933,999,900.00%+5,933,999,900.00%
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.00%+0.18%+1.32%+28.51%+15.77%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%+1.32%+2.99%-7.04%-11.59%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.7392 of 5 stars
2.33.00.04.13.93.33.1
SOLV
Solventum
N/AN/AN/AN/AN/AN/AN/AN/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
4.3819 of 5 stars
2.03.00.04.62.52.53.1
Teleflex Incorporated stock logo
TFX
Teleflex
4.422 of 5 stars
2.33.01.73.92.22.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.64
Moderate Buy$69.403.41% Upside
SOLV
Solventum
1.80
Reduce$65.7510.80% Upside
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
2.09
Hold$309.11-7.66% Downside
Teleflex Incorporated stock logo
TFX
Teleflex
2.63
Moderate Buy$257.2923.06% Upside

Current Analyst Ratings

Latest SOLV, TFX, SWAV, and GMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/30/2024
SOLV
Solventum
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSell$54.00
5/29/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$63.00 ➝ $72.00
5/20/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$60.00 ➝ $80.00
5/10/2024
SOLV
Solventum
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$70.00
5/9/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$83.00 ➝ $85.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$55.00 ➝ $60.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$60.00 ➝ $63.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$64.00 ➝ $70.00
5/8/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/3/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$240.00 ➝ $219.00
5/3/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
(Data available from 6/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.57B5.79$3.61 per share18.61$28.98 per share2.32
SOLV
Solventum
N/AN/AN/AN/A$22.30 per shareN/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$730.23M17.21$4.31 per share77.61$20.02 per share16.72
Teleflex Incorporated stock logo
TFX
Teleflex
$2.97B3.31$18.84 per share11.10$95.60 per share2.19

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$0.64104.8620.211.873.51%8.82%7.06%8/1/2024 (Estimated)
SOLV
Solventum
N/AN/A0.009.711.35N/AN/AN/A8/8/2024 (Estimated)
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$147.28M$4.2878.2154.342.4320.75%24.79%11.95%8/5/2024 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$356.33M$6.2333.5613.782.029.82%14.78%8.79%8/1/2024 (Estimated)

Latest SOLV, TFX, SWAV, and GMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024Q1 2024
SOLV
Solventum
$1.67$2.08+$0.41$2.79$1.99 billion$2.02 billion  
5/7/2024Q1 2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.55$0.72+$0.17$1.49$586.82 million$606.67 million    
5/6/2024Q1 2024
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$0.99$1.44+$0.45$1.44$207.69 million$218.80 million
5/2/2024Q1 2024
Teleflex Incorporated stock logo
TFX
Teleflex
$3.07$3.21+$0.14$6.10$726.85 million$737.80 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
SOLV
Solventum
N/AN/AN/AN/AN/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.360.65%N/A21.83%N/A

Latest SOLV, TFX, SWAV, and GMED Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Quarterly$0.340.68%5/14/20245/15/20246/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
2.33
1.29
SOLV
Solventum
2.16
1.81
1.33
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.97
13.81
12.61
Teleflex Incorporated stock logo
TFX
Teleflex
0.37
2.51
1.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
SOLV
Solventum
N/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
95.35%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.54%
SOLV
Solventum
N/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
3.40%
Teleflex Incorporated stock logo
TFX
Teleflex
1.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million110.27 millionOptionable
SOLV
Solventum
N/A172.71 millionN/AOptionable
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
1,46837.54 million36.27 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,50047.10 million46.43 millionOptionable

SOLV, TFX, SWAV, and GMED Headlines

Recent News About These Companies

Teleflex (NYSE:TFX) Sees Unusually-High Trading Volume
Teleflex (NYSE:TFX) Shares Gap Down to $219.79

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Solventum

NYSE:SOLV
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Shockwave Medical logo

Shockwave Medical

NASDAQ:SWAV
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Teleflex logo

Teleflex

NYSE:TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.